Cote Cote

Dr. Cote Cote


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Epigenomes
Verified
Journal Article
Open access
PDF file
CMClotilde Maurice
Clotilde Maurice
MDmathieu dalvai
mathieu dalvai
RLRomain Lambrot
Romain Lambrot
ADAstrid Deschênes
Astrid Deschênes
MSMarie-Pier Scott-Boyer
Marie-Pier Scott-Boyer
JBJanice L. Bailey
Janice L. Bailey
Due to the grasshopper effect, the Arctic food chain in Canada is contaminated with persistent organic pollutants (POPs) of industrial origin, including polychlorinated biphenyls and organochlorine pesticides. Exposure to POPs may be a contributor to the greater incidence of poor fetal growth, placental abnormalities, stillbirths, congenital defects and shortened lifespan in the Inuit population compared to non-Aboriginal Canadians. Although maternal exposure to POPs is well established to harm pregnancy outcomes, paternal transmission of the effects of POPs is a possibility that has not been well investigated. We used a rat model to test the hypothesis that exposure to POPs during gestation and suckling leads to developmental defects that are transmitted to subsequent generations via the male lineage. Indeed, developmental exposure to an environmentally relevant Arctic POPs mixture impaired sperm quality and pregnancy outcomes across two subsequent, unexposed generations and altered sperm DNA methylation, some of which are also observed for two additional generations. Genes corresponding to the altered sperm methylome correspond to health problems encountered in the Inuit population. These findings demonstrate that the paternal methylome is sensitive to the environment and that some perturbations persist for at least two subsequent generations. In conclusion, although many factors influence health, paternal exposure to contaminants plays a heretofore-underappreciated role with sperm DNA methylation contributing to the molecular underpinnings involved.

7 April 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
KDKatell Delanoë
Katell Delanoë
ESErwan Salaun
Erwan Salaun
RRRégis Rieu
Régis Rieu
CCCote Cote
Cote Cote
PPPhilippe Pibarot
Philippe Pibarot
VSViktória Stanová
Viktória Stanová
Mitral valve regurgitation is among the most prevalent valvular heart diseases and increases with age. Percutaneous therapy has emerged for the management of mitral regurgitation in high surgical risk patients. However, the long-term consequences of these interventions are still not fully understood due to their novelty and the difficulty of developing a strategy specific to the patient’s anatomy and/or pathology. To optimize these outcomes, an in vitro patient-specific approach could provide important insights for the most suitable strategy to use according to the patient profile. To ensure the reliability of this in vitro approach, the aim of this study was to reproduce the physiological behavior of the healthy native mitral valve for future applications. To do so, different silicon combinations reproducing the physiological anatomy of a healthy mitral valve were developed and tested under physiological hemodynamic conditions in a cardiac simulator. The hemodynamic and biomechanical behaviors of each mitral valve model were analyzed and compared to the physiological values provided in the literature. This study identified EcoFlex 00-50 and DragonSkin 10 (Smooth-On Inc., Easton, PA, USA) as the optimal silicon combination resulting in physiological strain values and hemodynamic parameters. These findings could be useful for future patient-specific applications, helping in the optimization of percutaneous mitral valve therapy.

17 October 2024 in Open Heart
Verified
Journal Article
Open access
PDF file
MFMarie-Ange Fleury
Marie-Ange Fleury
LTLionel Tastet
Lionel Tastet
JBJérémy Bernard
Jérémy Bernard
MSMylène Shen
Mylène Shen
RORomain Capoulade Inserm DR Grand Ouest
Romain Capoulade Inserm DR Grand Ouest
SHSébastien Hecht
Sébastien Hecht
Background: Bicuspid aortic valve (BAV) is often associated with a concomitant aortopathy. However, few studies have evaluated the effect of the aortic valve (AV) phenotype on the rate of dilation of the aorta. This study aimed to compare the progression rate of aorta dimensions according to AV phenotype (BAV vs tricuspid AV (TAV)), fusion type and sex in patients with aortic stenosis (AS). Methods: 310 patients with AS (224 TAV and 86 BAV) recruited in the Metabolic Determinants of the Progression of Aortic Stenosis study (PROGRESSA, NCT01679431) were included in this analysis. Doppler echocardiography was performed annually to assess AS severity and measure ascending aorta (AA) dimensions. Baseline and last follow-up visit measurements were used to assess the annualised change. Results: Median AA annualised change was larger in BAV versus TAV (0.33±0.65 mm/year vs 0.21±0.56 mm/year, p=0.04). In the whole cohort, BAV phenotype and higher low-density lipoprotein (LDL) levels were significantly associated with fast progression of AA dilation in univariate analysis (OR 1.80, 95% CI 1.08 to 2.98, p=0.02; 1.37, 95% CI 1.04 to 1.80, p=0.03, respectively). AA dilation rate did not vary according to the BAV subtype (p=0.142). Predictors of AA progression rate were different between valve phenotypes, with higher apolipoprotein B/apolipoprotein A-I ratio, higher baseline peak aortic jet velocity (Vpeak) and smaller baseline AA diameter in the TAV cohort (all p<0.05) versus absence of hypertension, higher LDL levels and smaller baseline AA diameter in the BAV cohort (all p<0.02). In men, higher baseline Vpeak and smaller baseline AA (p<0.001) were independently associated with increased annualised AA dilation, while in women, higher LDL levels (p=0.026) were independently associated with faster AA dilation. Conclusion: This study suggests that BAV is associated with faster dilation of the AA. Predictors of AA dilation are different between valve phenotype and sex, with higher LDL levels being associated with faster AA dilation in BAV.

1 January 2019
Verified
Book Chapter
Closed access
AZAnne-Sophie Zenses
Anne-Sophie Zenses
PPPhilippe Pibarot
Philippe Pibarot
MCMarie-Annick Clavel
Marie-Annick Clavel
EGEzequiel Guzzetti
Ezequiel Guzzetti
CCCote Cote
Cote Cote
ESErwan Salaun
Erwan Salaun

15 April 2022
Verified
Book Chapter
Open access
EGEzequiel Guzzetti
Ezequiel Guzzetti
CCCote Cote
Cote Cote
MCMarie-Annick Clavel
Marie-Annick Clavel
PPPhilippe Pibarot
Philippe Pibarot

1 June 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
SJSimon Jacob
Simon Jacob
SHSébastien Hecht
Sébastien Hecht
LTLionel Tastet
Lionel Tastet
MFMarie-Ange Fleury
Marie-Ange Fleury
KAKathia Abdoun
Kathia Abdoun
PPPhilippe Pibarot
Philippe Pibarot